Domestic pharmaceutical market to reach $130 billion by 2030: Economic Survey
1 year, 10 months ago

Domestic pharmaceutical market to reach $130 billion by 2030: Economic Survey

The Hindu  

India's domestic pharmaceutical market is estimated to reach $130 billion by 2030 and the pharma industry has sustained its growth momentum after the pandemic, according to the Economic Survey 2022-23. On the home front, the Survey said, "India's domestic pharmaceutical market is estimated at $41 billion in 2021 and is likely to grow to 65 billion by 2024 and is further expected to reach $130 billion by 2030." In terms of exports, the pre-Budget document stated that Indian pharmaceutical exports achieved a healthy growth of 24% in FY21, driven by COVID-19-induced demand for critical drugs and other supplies made to over 150 countries. "Until December 31, 2022, ceiling prices for 890 formulations of 358 drugs/medicines across various therapeutic categories under National List of Essential Medicines, 2015 have been fixed by National Pharmaceuticals Pricing Authority," it said.

India Growth Drugs Prices Survey Pharmaceutical Pharma Billion 2022 Nlem Pmbjp Domestic Pharmaceutical Market  billion  130  prices  growth  nlem  reach  market  2030  2022  drugs  exports  economic  pharmaceutical  domestic  survey  pharma

History of this topic

Medical devices maker Poly Medicure to focus on exports amid geopolitical shift
21 hours, 24 minutes ago

Medical devices maker Poly Medicure to focus on exports amid geopolitical shift

Live Mint  

Indian medical equipment manufacturer Poly Medicure Ltd. will continue to focus on export markets amid rising demand in the US and as global economies look to diversify their supply chains away from China, a top company official said. The US president-elect is also talking about this…So I think now it's more of a bolder approach," Poly Medicure's managing director Himanshu …

Bulk drug makers to benefit from price stability but need to improve efficiency to compete with Chinese rivals: Experts
1 month ago

Bulk drug makers to benefit from price stability but need to improve efficiency to compete with Chinese rivals: Experts

Live Mint  

Mumbai: Softening prices of active pharmaceutical ingredients are likely to stabilise in the months ahead and bring relief to Indian manufacturers, but they will still have to improve their operational efficiency to compete against Chinese rivals, industry executives and analysts said. API prices have been falling for the past 12-15 months, driven mainly by sharp price cuts by Chinese companies, …

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth in October
1 month, 1 week ago

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth in October

Live Mint  

India Pharma Market: Nifty Pharma index has seen a decline of 4% in November. While the selling pressure in the domestic markets has led to the this decline, the Indian Pharma Market growth also was not very encouraging in October albeit on a high base. In October’24, Indian Pharma Market continued to exhibit moderate growth of sub 5% Year on …

Pharma Exports in Two Months Rise 8.8% to $4.73 Billion: Pharmexcil Director General Udaya Bhaskar
5 months, 3 weeks ago

Pharma Exports in Two Months Rise 8.8% to $4.73 Billion: Pharmexcil Director General Udaya Bhaskar

Deccan Chronicle  

15 blockbuster drugs worth $ 112 billion to go off patent by 2029. Will provide a tremendous growth opportunity for Indian pharmaceutical companies by another $ 10 billion. This would provide a tremendous growth opportunity for Indian pharmaceutical companies by another $ 10 billion, said Pharmaceutical Export Promotion Council of India director general R Udaya Bhaskar. Off-patent drugs apart, PLI …

How is India streamlining the pharma sector? | Explained
7 months, 1 week ago

How is India streamlining the pharma sector? | Explained

The Hindu  

The story so far: India’s drug regulator, the Central Drugs Standard Control Organisation, has withdrawn powers delegated to State licensing authorities to issue NOCs for manufacture of unapproved, banned or new drugs for export purposes. This latest announcement covering drugs for export comes at a time when India has been under scrutiny for allegations of supplying substandard drugs causing health …

Q3 Result Preview: Sun Pharma to lead with highest qoq rise in the US-Jefferies
11 months ago

Q3 Result Preview: Sun Pharma to lead with highest qoq rise in the US-Jefferies

Live Mint  

Q3 Result Preview: The favorable trend seen by Indian Pharma companies on earnings growth during the first half of FY24 may continue during the December quarter too. Analysts at Jefferies India Pvt Ltd expect the current benign US pricing environment to continue and believe most of their coverage firms will clock sequential sales growth in the quarter. Lupin will Dr …

Outlook 2024: 2 key reasons why Jefferies expect subdued pharma returns vs 2023
11 months, 1 week ago

Outlook 2024: 2 key reasons why Jefferies expect subdued pharma returns vs 2023

Live Mint  

Outlook 2024: The Indian pharmaceutical companies saw a favorable 2023 as their earnings were aided by growth in the Domestic and US markets catching pace. Analysts at Jefferies India Pvt Ltd in their report on outlook for 2024 say that Pharma index outperformed Nifty by 14% in CY23 mainly led by valuation rerating. Lack of positive earnings surprise may keep …

India pharma industry to reach $130 billion by 2030
1 year ago

India pharma industry to reach $130 billion by 2030

The Hindu  

The Indian pharmaceutical industry is expected to reach $130 billion mark by 2030 said a top industry executive at the CPHI & PMEC India expo. This growth is propelled by expanding market opportunities, heightened demand in the USA, and critical shortages of medicines in the U.S. and Europe,” said Dr. Veeramani S.V., Chairman, Pharmaceuticals Export Promotion Council of India. Anil …

Pharma Star: India Steering Global Supply Chain Away from China - News18
1 year ago

Pharma Star: India Steering Global Supply Chain Away from China - News18

News 18  

India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. “India has started producing 45 APIs after …

Rise of the Indian biopharma industry
1 year ago

Rise of the Indian biopharma industry

Hindustan Times  

India is poised for a breakthrough in becoming the global leader in the biopharma sector. Over the past decade, the Indian biopharma industry has experienced a notable rise in its valuation, with the Covid-19 pandemic providing an all-important boost to the industry. Similarly, the Indian vaccines industry has also left an indelible mark on the global healthcare map, with experts …

Opinion: India could write the next chapter of global pharma triumph
1 year, 3 months ago

Opinion: India could write the next chapter of global pharma triumph

India Today  

India’s G20 presidency has significant implications for the pharmaceutical industry, focussing on improving global health emergency preparedness, fostering industry collaborations, and harnessing digital health potential. India’s pharma industry has established its position as a global hub for drug manufacturing, bolstered by a well-established domestic production infrastructure and a pool of highly-skilled, cost-effective workforce. New avenues for growth Not surprisingly, global …

Indian pharma industry to hit $57 billion by FY25
1 year, 5 months ago

Indian pharma industry to hit $57 billion by FY25

Live Mint  

New Delhi: Domestic pharmaceutical industry will likely hit $57 billion by FY25, along with expansion in operating margins by 100-150 basis points, according to a report by CareEdge Ratings. During FY18 to FY23, the Indian pharmaceutical industry has logged a a compound annual growth rate of 6-8%, primarily driven by an 8% increase in exports and a 6% rise in …

‘Pharma exports expected to touch $28 billion in FY24’
1 year, 6 months ago

‘Pharma exports expected to touch $28 billion in FY24’

The Hindu  

Indian pharma exports may touch $28 billion during the current fiscal against $25.39 billion in FY23, Udaya Bhaskar, Director General of the Pharmaceuticals Export Promotion Council of India, a body under the Department of Commerce said on Tuesday. When most commodities are not doing so well, India pharma made this and achieved this despite so many headwinds and global challenges,” …

‘Indian pharma industry likely to grow to $130 billion in size by 2030’
1 year, 6 months ago

‘Indian pharma industry likely to grow to $130 billion in size by 2030’

The Hindu  

The Indian pharmaceutical industry is projected to grow at a CAGR of over 10% to reach a size of $130 billion by 2030, industry officials said. Supported by the government’s policies and initiatives like ‘Pharma Vision 2020’ and ‘Make in India’, India aims to become a global pharmaceutical hub.” Stating that the pharmaceutical industry is moving towards transparency and visibility, …

India's pharma exports cross $25.3 billion
1 year, 7 months ago

India's pharma exports cross $25.3 billion

Deccan Chronicle  

Hyderabad: India’s pharmaceutical exports have maintained their upward trend, reaching $25.3 billion, roughly Rs 2,08,231 crore, for the financial year 2022-23 despite setbacks. Although the growth rate fluctuated during the year, witnessing growth in eight months and then declining in four months, the industry was nevertheless able to surpass its $24.5 billion record by 3.25%. Despite fluctuating growth rates during …

India FY23 exports defy global turmoil to hit record high
1 year, 8 months ago

India FY23 exports defy global turmoil to hit record high

Live Mint  

In a year of uncertainties worldwide, India exported a record $447 billion worth of goods in FY23, up about 6% from the previous year, commerce ministry data showed. At the same time, goods imports rose over 16% to touch $714 billion, widening the goods trade deficit to highest ever mark of $267 billion against the previous year’s $191 billion. “Although …

India\'s chemical demand likely to jump to USD 1,000 billion by 2040
1 year, 9 months ago

India\'s chemical demand likely to jump to USD 1,000 billion by 2040

Deccan Chronicle  

New Delhi: India is likely to account for more than a fifth of incremental global consumption for chemicals over the next two decades as domestic demand is projected to rise to USD 1,000 billion by 2040, McKinsey said in a report. In the report titled 'India: The next chemicals manufacturing hub', McKinsey said the country's chemical industry has been a …

Budget 2023: An Opportunity To Push India's Pharma Industry Development
1 year, 10 months ago

Budget 2023: An Opportunity To Push India's Pharma Industry Development

News 18  

The Union Budget 2023-24 will be presented on February 1 against the backdrop of a global recessionary fear. Several public sector schemes launched in the past few years, including the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, have focused on building last-mile infrastructure. Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance Secretary General Sudarshan …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 10 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

What pharmaceutical India has accomplished in 2022: What to expect in 2023?
1 year, 11 months ago

What pharmaceutical India has accomplished in 2022: What to expect in 2023?

Live Mint  

In light of the upcoming New Year celebrations, let's take a quick look at what Pharmaceutical India has accomplished in 2022. India's pharmaceutical industry has transformed from a volume creator to a value provider in 2022. The Indian pharmaceutical industry, however, took it as a challenge and developed vaccines that saved millions of lives. In addition, the Indian pharmaceutical industry …

Made-in-India COVID drugs emerge as life-savers in China, but a Chinese film had predicted so in 2018
2 years ago

Made-in-India COVID drugs emerge as life-savers in China, but a Chinese film had predicted so in 2018

Firstpost  

Dying to Survive, a film from 2018, was quite farsighted in its telling of a future happening. The Chinese comedy-drama starring Xu Zheng, takes inspiration from a true story — of a Chinese leukemia patient Lu Yong who smuggled cheap and generic cancer medicine Remember the 2011 film Contagion starring Matt Damon, Kate Winslet, Gwyneth Paltrow, among others, and how …

Pharma exports rise by 4.22% to $14.57 billion during April-October in current fiscal
2 years ago

Pharma exports rise by 4.22% to $14.57 billion during April-October in current fiscal

The Hindu  

Pharmaceutical exports from India registered a growth of 4.22% to reach $14.57 billion during the April-October period despite a negative trend last month, according to a senior official of an export promotion body under Government of India. Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India which is an organisation under the Ministry of Commerce, said he was …

India to post 6.5-7.1% growth in FY23: Deloitte
2 years, 1 month ago

India to post 6.5-7.1% growth in FY23: Deloitte

Live Mint  

A report by Deloitte India on Sunday said that India is likely to post a 6.5% to 7.1% economic growth in FY2022-23. The Deloitte report said that despite the Reserve Bank of India raising repo rates by 1.9 percentage points since April 2022, inflation has remained above its tolerance range for over 9 months now. Deloitte expects "India to post …

Focus on innovation, government-industry synergy key for India to become pharmacy of the world
2 years, 3 months ago

Focus on innovation, government-industry synergy key for India to become pharmacy of the world

Firstpost  

The Indian pharma industry is strongly positioned in terms of production capacity and is also committed to growth Indian pharma industry currently ranks third in terms of pharmaceutical production by volume. A multi-pronged approach to innovation The R&D and clinical trials in the Indian pharma industry are traditionally risk-averse as they face several obstacles that may stifle innovation, such as …

India takes another step towards becoming pharmacy of the world as exports grow by 103% since 2013-14
2 years, 7 months ago

India takes another step towards becoming pharmacy of the world as exports grow by 103% since 2013-14

Firstpost  

India’s top five pharma export destinations are the US, UK, South Africa, Russia and Nigeria. India’s pharma exports in 2021-22 sustained a positive growth despite the global trade disruptions and drop in demand for COVID-related medicines, it added. “Indian pharma companies enabled by their price competitiveness and good quality, have made a global mark, with 60 per cent of the …

Manufacturing in India Sees 210% Jump in FY22; Private Investment Picks Up: Goldman Sachs
2 years, 7 months ago

Manufacturing in India Sees 210% Jump in FY22; Private Investment Picks Up: Goldman Sachs

News 18  

New investments and ordering activities have seen a sharp pick-up in the financial year 2021-22, and the manufacturing sector, which has lagged for multiple years, saw a jump of 210 per cent, compared with the previous financial year 2020-21. The sector witnessed a 460 per cent jump in 2021-22 as against 2019-20, according to a report by Goldman Sachs. “Contract …

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter
2 years, 8 months ago

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

Live Mint  

The Indian pharmaceuticals sector has been under pressure from the ongoing Russia-Ukraine war as a majority of pharma companies have a strong presence in both countries. The report estimates EBITDA in 4QFY22E to be sequentially lower for the majority of Indian generic pharma companies on account of lower gross margins due to an increase in raw material costs and sustained …

Exports up 20% to $42 billion in March; reaches $420 billion in FY22
2 years, 8 months ago

Exports up 20% to $42 billion in March; reaches $420 billion in FY22

The Hindu  

The country's exports in March 2022 rose 19.76% to $42.22 billion on account of healthy performance by sectors such as petroleum products, engineering, and leather, even as trade deficit during the month widened to $18.51 billion. According to the data, the estimated value of services export increased 4.64% to $21.76 billion in March 2022. "The estimated value of services export …

India's Trade Deficit Rises 88% to $192 Billion in FY22, Says Govt; Details here
2 years, 8 months ago

India's Trade Deficit Rises 88% to $192 Billion in FY22, Says Govt; Details here

News 18  

India’s trade deficit rose 87.5 per cent to USD 192.41 billion in 2021-22 as against USD 102.63 billion in the previous year, the government data showed on Monday. The ministry said the country’s merchandise import last month stood at USD 59.07 billion, an increase of 20.79 per cent over USD 48.90 billion in the year-ago period. During March 2022, the …

Budgetary support could propel our quest for pharma innovation
2 years, 10 months ago

Budgetary support could propel our quest for pharma innovation

Live Mint  

The Indian pharmaceutical industry has been playing a key role in improving global health through its affordable and high-quality generic medicines. India will need to make exponential investments in R&D, manufacturing and digital transformations to become a global pharmaceutical innovation hub as well as achieve its vision of self-reliance in pharmaceuticals and biopharma. The government needs to urgently explore mechanisms …

What is the road ahead for Indian exports; will momentum continue?
3 years ago

What is the road ahead for Indian exports; will momentum continue?

Business Standard  

At the beginning of this fiscal, the Centre had set a merchandise export target of $400 billion for FY22, which at the time seemed ambitious. From April to November this year, they are up 51% to $263 billion and set to cross last year’s numbers by December.The rise in India’s exports could be attributed largely to the growth momentum in …

Over 20 Cr Doses in Stock & More on the Way, Vaccine Surplus May Push India to Start Commercial Exports
3 years, 1 month ago

Over 20 Cr Doses in Stock & More on the Way, Vaccine Surplus May Push India to Start Commercial Exports

News 18  

Sitting on a stock of more than 20 crore Covid-19 vaccine doses, the Narendra Modi government may start commercial exports soon, a top government official said. By December, India may have excess vaccine supply with a balance of more than 30 crore doses. Meanwhile, the government has already given permission to Pune-based Serum Institute of India to export 1 crore …

​25 Cr Pills, 50 Lakh Vials, Sales of Rs 2,800 Cr: Growth Story of India’s 2 anti-Covid Drugs
3 years, 2 months ago

​25 Cr Pills, 50 Lakh Vials, Sales of Rs 2,800 Cr: Growth Story of India’s 2 anti-Covid Drugs

News 18  

A total of 25 crore pills, 50 lakh vials and sales of Rs 2,800 crore — this is how Indians have purchased two key Covid-19 drugs remdesivir and favipiravir in the last 15 months. What data shows According to data from US-based pharma research company IQVIA, accessed by News18.com, India sold 52 lakh vials of remdesivir injection and around 1.5 …

Minimal impact of Covid-19 2.0 on the Indian pharma industry: ICRA
3 years, 5 months ago

Minimal impact of Covid-19 2.0 on the Indian pharma industry: ICRA

Live Mint  

The impact of Covid-19 on the Indian pharmaceutical companies was relatively limited in FY2021 owing to the inelastic demand for pharmaceutical products and resumption of imports of key input materials from China from March 2020 onwards, ICRA, an independent and professional investment Information and Credit Rating Agency said on Friday. The revenue growth for ICRA sample of 21 companies remained …

India exported 11 lakh Remdesivir injections in last 6 months: Govt sources
3 years, 8 months ago

India exported 11 lakh Remdesivir injections in last 6 months: Govt sources

India Today  

India has exported close to 11 lakh injections of Remdesivir, an anti-viral drug repurposed for Covid-19 treatment, in the last 6 months to more than 100 countries. A government source said Remdesivir injections were exported as its demand had tapered in India following a dip in Covid-19 cases from December to February. However, the shortage occurred as manufacturers cut back …

China still ‘largest source of critical items’ for India
3 years, 10 months ago

China still ‘largest source of critical items’ for India

The Hindu  

China still remains the largest source of critical imports for India, from mobile phone components to pharmaceutical ingredients, and India is working on a multi-pronged strategy to reduce this reliance, which is a bigger concern than the imbalance in trade. When somebody controls your production, that is a sentiment which raises concern.” PLI scheme Mr. Chadha said that India was …

India's Y-o-y Formulations' Market Growth Revives Back to 8.5% in December, Says Ind-Ra Report
3 years, 11 months ago

India's Y-o-y Formulations' Market Growth Revives Back to 8.5% in December, Says Ind-Ra Report

News 18  

The Indian pharmaceutical market grew 8.5 per cent year-on-year during December 2020, due to volume and price growth as well as new launches, India Ratings and Research said in a report. Accordingly, the report cited a YoY volume growth of 0.3 per cent, price growth of 5 per cent and products launches at 3.1 per cent during December 2020. “During …

Pharma market reports growth in September
4 years, 2 months ago

Pharma market reports growth in September

Deccan Chronicle  

Chennai: Notwithstanding the higher base, the pharma market grew 4.5 per cent in the month of September. Cardiac drugs grew by 17 per cent, vitamins, minerals and nutrients by 16.3 per cent and anti-diabetic therapy posted growth of 6.5 per cent last month. Meanwhile, Crisil expects pharma exports to grow by 11-12 per cent this fiscal, better than last year’s …

Pharma sales back in red in August as anti-infective drugs struggle
4 years, 3 months ago

Pharma sales back in red in August as anti-infective drugs struggle

Live Mint  

New Delhi: Sales of medicines in India declined again in August after two months of growth as the struggle for anti-infective drugs continued amid the covid-19 pandemic, data from market research firm AIOCD-AWACS showed. In August, sales of cardiac and anti-diabetic drugs grew 11.5% and 1.6% respectively, while vitamins also grew 6.2%. On the other hand, anti-infective drugs continued to …

Discover Related